Seasonal variation in respiratory syncytial virus epidemics in the Gambia, West Africa

Pediatric Infectious Disease Journal

Volumn 23, Issue 1, 2004, Pages 73-74

  Van Der Sande, Marianne A B ^a   Goetghebuer, Tessa ^a,b   Sanneh, Mariama ^a   Whittle, Hilton C ^a   Weber, Martin W ^a,c  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Epidemiology; Respiratory syncytial virus; Seasonality; The Gambia

Indexed keywords

AFRICA; ARTICLE; CHILD; COMPARATIVE STUDY; DEVELOPING COUNTRY; EPIDEMIC; FEMALE; GAMBIA; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MALE; MORBIDITY; NASOPHARYNX; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; SEASON; SEASONAL VARIATION; VIROLOGY; VIRUS INFECTION; VIRUS TRANSMISSION;

DEVELOPING COUNTRIES; DISEASE OUTBREAKS; FEMALE; GAMBIA; HUMANS; INCIDENCE; MALE; NASOPHARYNX; POPULATION SURVEILLANCE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY TRACT INFECTIONS; RISK ASSESSMENT; SEASONS;

EID: 0842325965     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000105183.12781.06     Document Type: Article

References (13)

1. Simoes EAF. Respiratory syncytial virus infection. Lancet 1999;354:847-52.
2. Weber MW, Mulholland KM, Greenwood BM. Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health 1998;4:268-80.
3. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000;161:1501-7.
4. van der Sande MAB, Kidd M, Goetghebuer T, et al. Severe respiratory syncytial virus infection in early life is associated with increased type 2 cytokine production in Gambian children. J Clin Exp Allergy 2002;32:1430-6.
5. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and Respiratory Syncytial Virus in the United States. JAMA 2003;289:179-86.
6. Krilov LR. Respiratory syncytial virus: update on infection, treatment, and prevention. Curr Infect Dis Rep 2001;3: 242-6.
7. Weber A, Weber M, Milligan P. Modelling epidemics caused by respiratory syncytial virus (RSV). Math Biosci 2001;172: 95-113.
8. Cane PA, Weber M, Sanneh M, Dackour R, Pringle CR, Whittle H. Molecular epidemiology of respiratory syncytial virus in The Gambia. Epidemiol Infect. 1999;122:155-60.
9. Weber MW, Milligan P, Hilton S, et al. Risk factors for severe respiratory syncytial virus infection leading to hospital admission in children in the Western Region of The Gambia. Int J Epidemiol 1999; 28: 157-62.
10. Chew FT, Doraisingham S, Ling AE, Kumarasinghe G, Lee BW. Seasonal trends of viral respiratory tract infections in the tropics. Epidemiol Infect 1998;121:121-8.
11. Waris M. Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B. J Infect Dis 1991;163:464-9.
12. Doraisingham S, Goh KT, Ling AE. Epidemiology of viral infections in Singapore. Ann Acad Med Singapore 1987;16: 243-9.
13. Piedra PA. Clinical experience with respiratory syncytial virus vaccines. Pediatr Infect Dis J 2003;22(Suppl):S94-9.